User profiles for Lucas J. Adams
 | Lucas J. AdamsMD-PhD Candidate, Washington University Verified email at wustl.edu Cited by 1243 |
[PDF][PDF] A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2
The coronavirus disease 2019 pandemic has made deployment of an effective vaccine a
global health priority. We evaluated the protective activity of a chimpanzee adenovirus-…
global health priority. We evaluated the protective activity of a chimpanzee adenovirus-…
[PDF][PDF] A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants with increased transmissibility and potential resistance, antibodies and vaccines with …
variants with increased transmissibility and potential resistance, antibodies and vaccines with …
[PDF][PDF] A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
The development of an effective vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a …
coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a …
[PDF][PDF] Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of
human infections, and an effective vaccine is critical to mitigate coronavirus-induced disease …
human infections, and an effective vaccine is critical to mitigate coronavirus-induced disease …
[PDF][PDF] An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
SARS-CoV-2 variants that attenuate antibody neutralization could jeopardize vaccine efficacy.
We recently reported the protective activity of an intranasally administered spike protein-…
We recently reported the protective activity of an intranasally administered spike protein-…
[PDF][PDF] Expression of the Mxra8 receptor promotes alphavirus infection and pathogenesis in mice and Drosophila
Mxra8 is a recently described receptor for multiple alphaviruses, including Chikungunya (CHIKV),
Mayaro (MAYV), Ross River (RRV), and O'nyong nyong (ONNV) viruses. To determine …
Mayaro (MAYV), Ross River (RRV), and O'nyong nyong (ONNV) viruses. To determine …
[PDF][PDF] A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection
Most neutralizing anti-SARS-CoV-2 monoclonal antibodies (mAbs) target the receptor binding
domain (RBD) of the spike (S) protein. Here, we characterize a panel of mAbs targeting …
domain (RBD) of the spike (S) protein. Here, we characterize a panel of mAbs targeting …
Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8
MXRA8 is a receptor for chikungunya (CHIKV) and other arthritogenic alphaviruses with
mammalian hosts. However, mammalian MXRA8 does not bind to alphaviruses that infect …
mammalian hosts. However, mammalian MXRA8 does not bind to alphaviruses that infect …
[HTML][HTML] Structural and functional basis of VLDLR receptor usage by Eastern equine encephalitis virus
The very low-density lipoprotein receptor (VLDLR) is comprised of eight LDLR type A (LA)
domains and supports entry of distantly related Eastern equine encephalitis (EEEV) and …
domains and supports entry of distantly related Eastern equine encephalitis (EEEV) and …
[HTML][HTML] The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses
Members of the low-density lipoprotein receptor (LDLR) family, including LDLRAD3, VLDLR,
and ApoER2, were recently described as entry factors for different alphaviruses. However, …
and ApoER2, were recently described as entry factors for different alphaviruses. However, …
